Treatment of Tinea Corporis

First-Line Treatment

The American Academy of Dermatology recommends topical antifungal therapy applied for 2-4 weeks as the first-line treatment for mild to moderate tinea corporis 1
Clotrimazole cream is effective when applied twice daily for 2-4 weeks 1
Miconazole cream is effective when applied twice daily for 2-4 weeks 1
Terbinafine 1% gel is effective when applied once daily for 1-2 weeks, with a shorter duration that may improve compliance 2

The Infectious Diseases Society of America indicates that oral antifungal therapy is necessary when the infection is extensive, resistant to topical treatment, involves multiple sites, is chronic or recurrent, or occurs in immunocompromised patients 1
Itraconazole 100 mg daily for 15 days is highly effective with an 87% mycological cure rate and covers both Trichophyton and Microsporum species 1, 2
Terbinafine 250 mg daily for 1-2 weeks is particularly effective against Trichophyton tonsurans and has superior efficacy for Trichophyton species infections 1, 2

For Trichophyton species, terbinafine is the superior treatment option 1, 2
For Microsporum species or unknown organism, itraconazole is the preferred treatment option 2

The American Academy of Dermatology recommends obtaining baseline liver function tests before initiating terbinafine or itraconazole, especially in patients with pre-existing hepatic abnormalities 1, 2
Itraconazole has enhanced toxicity with certain medications, including warfarin, antihistamines, antipsychotics, midazolam, digoxin, cisapride, and simvastatin 2
Itraconazole is contraindicated in heart failure 2

The British Association of Dermatologists recommends accurate diagnosis through potassium hydroxide (KOH) preparation or fungal culture before initiating treatment 3
Collecting specimens via scalpel scraping from the active border of the lesion is an effective method for diagnosis 3
KOH microscopy provides rapid diagnosis 2
Culture on Sabouraud agar confirms the causative organism and guides therapy 2, 3

The American Academy of Dermatology recommends that the definitive endpoint must be mycological cure (negative microscopy and culture), not just clinical improvement 2
Repeat mycology sampling at the end of the standard treatment period 1, 2
If clinical improvement occurs but mycology remains positive, continue current therapy for an additional 2-4 weeks 2

The Centers for Disease Control and Prevention recommends implementing comprehensive prevention strategies to avoid reinfection, including avoiding skin-to-skin contact with infected individuals, not sharing personal items, covering lesions during treatment, and cleaning contaminated items with disinfectant or 2% sodium hypochlorite solution 1, 2, 3
Screening and treating family members is necessary if the infection is caused by anthropophilic species like T. tonsurans (>50% of family members may be affected) 2, 3